Matthew Vincent Dolan

Companies

• DexcomSVP Corporate Development Mar 10, 2022 to Jan 30, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Dexcom DXCM42,044 shares²$3.6M at $86.04Jan 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 29, 2025Sold 1,183 shares at $86.91 of Dexcom²
• Jan 28, 2025Granted 3,048 shares of Dexcom²
• May 15, 2024Sold 2,423 shares at $126.58 of Dexcom³
• Apr 15, 2024Sold 1,990 shares at $137.81 of Dexcom⁴
• Mar 15, 2024Sold 1,003 shares at $131.39 of Dexcom⁵
• Mar 15, 2024Sold 1,314 shares at $130.77 of Dexcom⁵
• Mar 15, 2024Sold 1,886 shares at $129.18 of Dexcom⁵
• Mar 12, 2024Sold 6,710 shares at $134.41 of Dexcom⁶
• Mar 8, 2024Granted 21,711 shares of Dexcom⁷
• Sep 1, 2023Sold 56 shares at $102.32 of Dexcom⁸
• Mar 16, 2023Sold 2,303 shares at $115.00 of Dexcom⁹
• Mar 13, 2023Sold 6,229 shares at $106.27 of Dexcom¹⁰
• Mar 10, 2023Returned to company 787 shares at $111.40 of Dexcom¹⁰
• Mar 10, 2023Returned to company 2,397 shares at $111.40 of Dexcom¹⁰
• Mar 10, 2023Returned to company 1,650 shares at $111.40 of Dexcom¹⁰
• Mar 10, 2023Returned to company 1,370 shares at $111.40 of Dexcom¹⁰
• Mar 8, 2023Granted 21,769 shares of Dexcom¹¹
• Mar 6, 2023Sold 226 shares at $114.40 of Dexcom¹²
• Sep 1, 2022Sold 5 shares at $81.63 of Dexcom¹³
• Mar 17, 2022Sold 484 shares at $450.00 of Dexcom¹⁴
• Mar 16, 2022Sold 686 shares at $425.00 of Dexcom¹⁴
• Mar 15, 2022Sold 1,016 shares at $412.41 of Dexcom¹⁴
• Mar 9, 2022Returned to company 541 shares at $406.06 of Dexcom¹⁵
• Mar 9, 2022Returned to company 489 shares at $406.06 of Dexcom¹⁵
• Mar 9, 2022Returned to company 192 shares at $406.06 of Dexcom¹⁵